New substituted tricyclic compounds of formula (I) are described, wherein R1, R2, X, Y, Z are herein defined, having protein kinase inhibiting activity. The invention includes methods to prepare the compounds of formula (I), pharmaceutical compositions containing them, and their use in therapy, in particular for the treatment of diseases caused by and/or associated with dysregulated activity of protein kinase.
本发明涉及公式(I)的新取代
三环化合物,其中R1、R2、X、Y、Z在此定义,具有蛋白激酶抑制活性。本发明包括制备公式(I)化合物的方法,含有它们的药物组合物,以及它们在治疗中的应用,特别是用于治疗由蛋白激酶失调活性引起和/或相关的疾病。